Toward microRNA-based therapeutics for heart disease: the sense in antisense.
暂无分享,去创建一个
[1] L. Lim,et al. Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing. , 2006, RNA.
[2] Michael T. McManus,et al. Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2 , 2007, Cell.
[3] G. Hannon,et al. Processing of primary microRNAs by the Microprocessor complex , 2004, Nature.
[4] John McAnally,et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. , 2008, Developmental cell.
[5] R. Quaife,et al. Coordinate Changes in Myosin Heavy Chain Isoform Gene Expression Are Selectively Associated With Alterations in Dilated Cardiomyopathy Phenotype , 2002, Molecular medicine.
[6] B. Bruneau,et al. The Homeodomain Transcription Factor Irx5 Establishes the Mouse Cardiac Ventricular Repolarization Gradient , 2005, Cell.
[7] S. Homma,et al. Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.
[8] L. Leinwand,et al. Myosin heavy chain gene expression in human heart failure. , 1997, The Journal of clinical investigation.
[9] M. Eldar,et al. The role of insulin-like and basic fibroblast growth factors on ischemic and infarcted myocardium: a mini review. , 1997, International journal of cardiology.
[10] J. Robbins,et al. Impact of beta-myosin heavy chain expression on cardiac function during stress. , 2004, Journal of the American College of Cardiology.
[11] E. Olson,et al. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. , 2007, The Journal of clinical investigation.
[12] Xiaoxia Qi,et al. Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA , 2007, Science.
[13] S. Kauppinen,et al. LNA-mediated microRNA silencing in non-human primates , 2008, Nature.
[14] Stefanie Dimmeler,et al. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. , 2008, Cardiovascular research.
[15] Henning Urlaub,et al. Single-Stranded Antisense siRNAs Guide Target RNA Cleavage in RNAi , 2002, Cell.
[16] Yanjie Lu,et al. MicroRNA miR-133 Represses HERG K+ Channel Expression Contributing to QT Prolongation in Diabetic Hearts* , 2007, Journal of Biological Chemistry.
[17] K. Fujiwara,et al. ECM remodeling in hypertensive heart disease. , 2007, The Journal of clinical investigation.
[18] V. Ambros,et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.
[19] V. Kim,et al. The nuclear RNase III Drosha initiates microRNA processing , 2003, Nature.
[20] K. Esser,et al. MicroRNA-1 and microRNA-133a expression are decreased during skeletal muscle hypertrophy. , 2007, Journal of applied physiology.
[21] R. Knight,et al. Clinical implications of apoptosis in ischemic myocardium. , 2006, Current problems in cardiology.
[22] C. Sander,et al. A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.
[23] L. Leinwand,et al. Myosin heavy chain isoform expression in the failing and nonfailing human heart. , 2000, Circulation research.
[24] C. Croce,et al. MiR-15a and miR-16-1 cluster functions in human leukemia , 2008, Proceedings of the National Academy of Sciences.
[25] D. Mann. MicroRNAs and the failing heart. , 2007, The New England journal of medicine.
[26] N. Rajewsky,et al. Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.
[27] Robert Langer,et al. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics , 2008, Nature Biotechnology.
[28] W. Filipowicz,et al. Repression of protein synthesis by miRNAs: how many mechanisms? , 2007, Trends in cell biology.
[29] M. Stoffel,et al. Specificity, duplex degradation and subcellular localization of antagomirs , 2007, Nucleic acids research.
[30] J. Nemunaitis,et al. Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? , 2008, Cancer Gene Therapy.
[31] Phillip D Zamore,et al. Sequence-Specific Inhibition of Small RNA Function , 2004, PLoS biology.
[32] W. Filipowicz,et al. Relief of microRNA-Mediated Translational Repression in Human Cells Subjected to Stress , 2006, Cell.
[33] Mark A Behlke,et al. Design of active small interfering RNAs. , 2007, Current opinion in molecular therapeutics.
[34] Danish Sayed,et al. MicroRNAs Play an Essential Role in the Development of Cardiac Hypertrophy , 2007, Circulation research.
[35] Margaret S. Ebert,et al. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells , 2007, Nature Methods.
[36] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[37] Sek Won Kong,et al. Altered microRNA expression in human heart disease. , 2007, Physiological genomics.
[38] Danish Sayed,et al. MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. , 2008, Molecular biology of the cell.
[39] C. Croce,et al. MicroRNA-133 controls cardiac hypertrophy , 2007, Nature Medicine.
[40] M. Mann,et al. miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. , 2002, Genes & development.
[41] Yanjie Lu,et al. Retracted: Novel approaches for gene‐specific interference via manipulating actions of microRNAs: Examination on the pacemaker channel genes HCN2 and HCN4 , 2007, Journal of cellular physiology.
[42] G. Hannon,et al. Control of translation and mRNA degradation by miRNAs and siRNAs. , 2006, Genes & development.
[43] K. McDonald,et al. Small Amounts of &agr;-Myosin Heavy Chain Isoform Expression Significantly Increase Power Output of Rat Cardiac Myocyte Fragments , 2002, Circulation research.
[44] K. Kamiński,et al. [Angiogenesis in heart]. , 2007, Przeglad lekarski.
[45] E. Olson,et al. Hypertrophy of the heart: a new therapeutic target? , 2004, Circulation.
[46] Jennifer Couzin,et al. MicroRNAs Make Big Impression in Disease After Disease , 2008, Science.
[47] A. Silahtaroglu,et al. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver , 2007, Nucleic acids research.
[48] F. Slack,et al. Small non-coding RNAs in animal development , 2008, Nature Reviews Molecular Cell Biology.
[49] C. Croce,et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[50] E. Olson,et al. Toward transcriptional therapies for the failing heart: chemical screens to modulate genes. , 2005, The Journal of clinical investigation.
[51] R. Shiekhattar,et al. The Microprocessor complex mediates the genesis of microRNAs , 2004, Nature.
[52] Matthias John,et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs , 2004, Nature.
[53] Shuomin Zhu,et al. miR-21-mediated tumor growth , 2007, Oncogene.
[54] Richard J Jackson,et al. MicroRNAs repress translation of m7Gppp-capped target mRNAs in vitro by inhibiting initiation and promoting deadenylation. , 2007, Genes & development.
[55] Haruchika Masuda,et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization , 1999, Nature Medicine.
[56] Jian-Fu Chen,et al. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. , 2007, Journal of molecular and cellular cardiology.
[57] Thomas Thum,et al. MicroRNAs: novel regulators in cardiac development and disease. , 2008, Cardiovascular research.
[58] T. Sanborn,et al. Therapeutic Angiogenesis: A Biologic Bypass , 2004, Cardiology.
[59] Chaoqian Xu,et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2 , 2011, Nature Medicine.
[60] Ru-Fang Yeh,et al. miR-126 regulates angiogenic signaling and vascular integrity. , 2008, Developmental cell.
[61] Jeffrey E. Thatcher,et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis , 2008, Proceedings of the National Academy of Sciences.
[62] Chunxiang Zhang,et al. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? , 2007, The American journal of pathology.
[63] George A Calin,et al. MicroRNA fingerprints during human megakaryocytopoiesis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[64] Thomas Thum,et al. MicroRNAs in the Human Heart: A Clue to Fetal Gene Reprogramming in Heart Failure , 2007, Circulation.
[65] Mark Graham,et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. , 2006, Cell metabolism.
[66] E. Olson,et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure , 2006, Proceedings of the National Academy of Sciences.